Items where authors include "Reed, J."
Article
Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370
Bacalja, A. orcid.org/0000-0002-2440-1488, Nichols, T.P. orcid.org/0000-0002-8648-1276, Robinson, B. orcid.org/0000-0002-2983-0206 et al. (28 more authors) (2024) Postdigital videogames literacies: thinking with, through, and beyond James Gee’s learning principles. Postdigital Science and Education, 6 (4). pp. 1103-1142. ISSN 2524-485X
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587
Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736
Mosenzon, O., Blicher, T.M., Rosenlund, S. et al. (113 more authors) (2019) Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial. The Lancet Diabetes & Endocrinology, 7 (7). pp. 515-527. ISSN 2213-8587
Webb, E.A., Elliott, L., Carlin, D. et al. (11 more authors) (2018) Quantitative MRI brain in congenital adrenal hyperplasia: in vivo assessment of the cognitive and structural impact of steroid hormones. Journal of Clinical Endocrinology and Metabolism, 103 (4). pp. 1330-1341. ISSN 0021-972X
Conference or Workshop Item
Savic, S. orcid.org/0000-0001-7910-0554, Reed, J., El-Shanawany, T. et al. (5 more authors) (2025) P072 Improvement across work productivity and quality of life with remibrutinib treatment in patients with chronic spontaneous urticaria in the REMIX-1/2 trials. In: 105th Annual Meeting of the British Association of Dermatologists, 01-03 Jul 2025, Glasgow, UK.
Reed, J., Savic, S. orcid.org/0000-0001-7910-0554, El-Shanawany, T. et al. (4 more authors) (2025) P133 Perceptions of patients and physicians from the UK of the burden of chronic spontaneous urticaria: results from the Urticaria Voices study. In: 105th Annual Meeting of the British Association of Dermatologists, 01-03 Jul 2025, Glasgow, UK.
Reed, J., Savic, S. orcid.org/0000-0001-7910-0554, El-Shanawany, T. et al. (4 more authors) (2025) PS07 (P113) Perceptions of patients and physicians from the UK of the burden of chronic spontaneous urticaria: results from the Urticaria Voices study. In: 105th Annual Meeting of the British Association of Dermatologists, 01-03 Jul 2025, Glasgow, UK.